These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 11319518)

  • 1. Endothelin and diabetic nephropathy: a new pathogenetic factor?
    Meli S; Bruno CM
    Panminerva Med; 2001 Mar; 43(1):45-8. PubMed ID: 11319518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin: emerging role in diabetic vascular complications.
    Hopfner RL; Gopalakrishnan V
    Diabetologia; 1999 Dec; 42(12):1383-94. PubMed ID: 10651255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure.
    Pfab T; Thöne-Reineke C; Theilig F; Lange I; Witt H; Maser-Gluth C; Bader M; Stasch JP; Ruiz P; Bachmann S; Yanagisawa M; Hocher B
    J Am Soc Nephrol; 2006 Apr; 17(4):1082-9. PubMed ID: 16495378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of C-peptide in the pathogenesis of diabetic nephropathy].
    Martina V; Maestroni A; Maestroni S; Zerbini G
    G Ital Nefrol; 2010; 27(3):240-8. PubMed ID: 20540017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endothelin in chronic renal failure--developments in renal involvement.
    Richter CM
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii36-8. PubMed ID: 16987832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endothelin-1 and nitric oxide in the pathogenesis of hypertension in diabetic patients.
    Tomić M; Galesić K; Morović-Vergles J; Romić Z; Mikulić I
    Coll Antropol; 2008 Mar; 32(1):93-8. PubMed ID: 18496905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in pathogenetic mechanisms of diabetic nephropathy.
    Nicholas SB
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1319-25. PubMed ID: 14984004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of proteinuric diabetic and nondiabetic renal diseases: a possible role for renal endothelin.
    Remuzzi G; Benigni A
    Kidney Int Suppl; 1997 Mar; 58():S66-8. PubMed ID: 9067947
    [No Abstract]   [Full Text] [Related]  

  • 13. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
    Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications.
    Navarro JF; Mora-Fernández C
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):441-50. PubMed ID: 17113815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of diabetic nephropathy.
    Dronavalli S; Duka I; Bakris GL
    Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):444-52. PubMed ID: 18607402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic nephropathy: the role of blood pressure and extra-cellular volume in its pathogenesis and treatment].
    Braam B; de Koning EJ; Mees EJ
    Ned Tijdschr Geneeskd; 2004 Jan; 148(5):212-7. PubMed ID: 14983575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic nephropathy: from mechanisms to rational therapies.
    Giunti S; Barit D; Cooper ME
    Minerva Med; 2006 Jun; 97(3):241-62. PubMed ID: 16855519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy.
    Chang JM; Kuo MC; Kuo HT; Chiu YW; Chen HC
    J Lab Clin Med; 2005 Oct; 146(4):210-5. PubMed ID: 16194682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of diabetic nephropathy in type 1 diabetic patients.
    Najafian B; Mauer M
    Diabetes Res Clin Pract; 2009 Jan; 83(1):1-8. PubMed ID: 19070384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():50-67. PubMed ID: 19335747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.